
CVS Health Corp
NYSE:CVS

Intrinsic Value
The intrinsic value of one
CVS
stock under the Base Case scenario is
143.83
USD.
Compared to the current market price of 69.45 USD,
CVS Health Corp
is
Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
CVS Health Corp
Fundamental Analysis

Revenue & Expenses Breakdown
CVS Health Corp
Balance Sheet Decomposition
CVS Health Corp
Current Assets | 68.6B |
Cash & Short-Term Investments | 11B |
Receivables | 36.5B |
Other Current Assets | 21.2B |
Non-Current Assets | 184.6B |
Long-Term Investments | 28.9B |
PP&E | 28.9B |
Intangibles | 118.6B |
Other Non-Current Assets | 8.1B |
Free Cash Flow Analysis
CVS Health Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
CVS Health Corp
Revenue
|
372.8B
USD
|
Cost of Revenue
|
-321.4B
USD
|
Gross Profit
|
51.4B
USD
|
Operating Expenses
|
-41.4B
USD
|
Operating Income
|
10B
USD
|
Other Expenses
|
-5.4B
USD
|
Net Income
|
4.6B
USD
|
CVS Profitability Score
Profitability Due Diligence
CVS Health Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
CVS Health Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CVS Solvency Score
Solvency Due Diligence
CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Score
CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CVS Price Targets Summary
CVS Health Corp
According to Wall Street analysts, the average 1-year price target for
CVS
is 76.17 USD
with a low forecast of 60.6 USD and a high forecast of 94.5 USD.
Dividends
Current shareholder yield for CVS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CVS
stock under the Base Case scenario is
143.83
USD.
Compared to the current market price of 69.45 USD,
CVS Health Corp
is
Undervalued by 52%.